サマリー

ヒト成長ホルモンの世界市場 2022-2026 年
Technavioは、ヒト成長ホルモン市場を監視しており、それは2022-2026年の間に11億6000万ドルで、予測期間中に5.44％のCAGRで進行することが用意されています。当レポートでは、ヒト成長ホルモン市場の全体的な分析、市場規模と予測、トレンド、成長ドライバー、課題、さらに約25社のベンダーを網羅したベンダー分析などを提供しています。
現在の世界市場のシナリオ、最新のトレンドとドライバー、市場全体の環境に関する最新の分析を提供しています。市場は、アドヒアランス向上のための長時間作用型および針なし送達の開発、新たな適応症に対するヒト成長ホルモン補充療法のFDA承認、ヒト成長ホルモンの強力なパイプラインによって牽引されています。
ヒト成長ホルモン市場の分析には、アプリケーションセグメントと地理的展望が含まれます。
Technavioのヒト成長ホルモン市場は、以下のようにセグメント化されています。
アプリケーション別
- 成長ホルモン欠乏症
- ISS
- ターナー症候群
- PWS
- その他
地域別状況
- 北アメリカ
- 欧州
- アジア
- その他の地域 (ROW)
本調査では、成長障害の発生率の増加が、今後数年間のヒト成長ホルモン市場の成長を促進する主要な理由の1つであることを確認しています。また、バイオシミラーの市場参入の影響はなく、先進的な技術が市場の大きな需要につながると考えられます。
Technavio社は、複数のソースからのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。ヒト成長ホルモン市場に関する弊社のレポートは、以下の分野を対象としています。
- ヒト成長ホルモン市場のサイジング
- ヒト成長ホルモン市場の予測
- ヒト成長ホルモン市場の産業分析
Technavioの強力なベンダー分析は、顧客が市場での地位を向上できるように設計されており、これに沿って、本レポートでは、Abbott Laboratories、Anhui Anke Biotechnology Group Co.Ltd.、Ascendis Pharma AS、F. Hoffmann La Roche Ltd.、Ferring B.V.、Ipsen Pharma、Merck and Co.Inc.、Novo Nordisk AS、およびPfizer Inc.です。また、ヒト成長ホルモン市場の分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が今後訪れるすべての成長機会を戦略的に活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報および二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/human-growth-hormone-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細な姿を提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Application
o 5.1 Market segments
o Exhibit 24: Chart on Application - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Application - Market share 2021-2026 (%)
o 5.2 Comparison by Application
o Exhibit 26: Chart on Comparison by Application
o Exhibit 27: Data Table on Comparison by Application
o 5.3 Growth hormone deficiency - Market size and forecast 2021-2026
o Exhibit 28: Chart on Growth hormone deficiency - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Growth hormone deficiency - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Growth hormone deficiency - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Growth hormone deficiency - Year-over-year growth 2021-2026 (%)
o 5.4 ISS - Market size and forecast 2021-2026
o Exhibit 32: Chart on ISS - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on ISS - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on ISS - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on ISS - Year-over-year growth 2021-2026 (%)
o 5.5 Turner syndrome - Market size and forecast 2021-2026
o Exhibit 36: Chart on Turner syndrome - Market size and forecast 2021-2026 ($ million)
o Exhibit 37: Data Table on Turner syndrome - Market size and forecast 2021-2026 ($ million)
o Exhibit 38: Chart on Turner syndrome - Year-over-year growth 2021-2026 (%)
o Exhibit 39: Data Table on Turner syndrome - Year-over-year growth 2021-2026 (%)
o 5.6 PWS - Market size and forecast 2021-2026
o Exhibit 40: Chart on PWS - Market size and forecast 2021-2026 ($ million)
o Exhibit 41: Data Table on PWS - Market size and forecast 2021-2026 ($ million)
o Exhibit 42: Chart on PWS - Year-over-year growth 2021-2026 (%)
o Exhibit 43: Data Table on PWS - Year-over-year growth 2021-2026 (%)
o 5.7 Others - Market size and forecast 2021-2026
o Exhibit 44: Chart on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 45: Data Table on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 46: Chart on Others - Year-over-year growth 2021-2026 (%)
o Exhibit 47: Data Table on Others - Year-over-year growth 2021-2026 (%)
o 5.8 Market opportunity by Application
o Exhibit 48: Market opportunity by Application ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 49: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 50: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 51: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 52: Chart on Geographic comparison
o Exhibit 53: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 54: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 58: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 62: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 66: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 70: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Denmark - Market size and forecast 2021-2026
o Exhibit 74: Chart on Denmark - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on Denmark - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on Denmark - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on Denmark - Year-over-year growth 2021-2026 (%)
o 7.9 China - Market size and forecast 2021-2026
o Exhibit 78: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 79: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 80: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.10 Canada - Market size and forecast 2021-2026
o Exhibit 82: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 83: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 84: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 85: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.11 India - Market size and forecast 2021-2026
o Exhibit 86: Chart on India - Market size and forecast 2021-2026 ($ million)
o Exhibit 87: Data Table on India - Market size and forecast 2021-2026 ($ million)
o Exhibit 88: Chart on India - Year-over-year growth 2021-2026 (%)
o Exhibit 89: Data Table on India - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 90: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 91: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 92: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 93: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 94: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 95: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 96: Matrix on vendor position and classification
o 10.3 Abbott Laboratories
o Exhibit 97: Abbott Laboratories - Overview
o Exhibit 98: Abbott Laboratories - Business segments
o Exhibit 99: Abbott Laboratories - Key offerings
o Exhibit 100: Abbott Laboratories - Segment focus
o 10.4 Anhui Anke Biotechnology Group Co. Ltd.
o Exhibit 101: Anhui Anke Biotechnology Group Co. Ltd. - Overview
o Exhibit 102: Anhui Anke Biotechnology Group Co. Ltd. - Product / Service
o Exhibit 103: Anhui Anke Biotechnology Group Co. Ltd. - Key offerings
o 10.5 Ascendis Pharma AS
o Exhibit 104: Ascendis Pharma AS - Overview
o Exhibit 105: Ascendis Pharma AS - Product / Service
o Exhibit 106: Ascendis Pharma AS - Key offerings
o 10.6 F. Hoffmann La Roche Ltd.
o Exhibit 107: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 108: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 109: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 110: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 111: F. Hoffmann La Roche Ltd. - Segment focus
o 10.7 Ferring B.V.
o Exhibit 112: Ferring B.V. - Overview
o Exhibit 113: Ferring B.V. - Product / Service
o Exhibit 114: Ferring B.V. - Key offerings
o 10.8 Ipsen Pharma
o Exhibit 115: Ipsen Pharma - Overview
o Exhibit 116: Ipsen Pharma - Business segments
o Exhibit 117: Ipsen Pharma - Key offerings
o Exhibit 118: Ipsen Pharma - Segment focus
o 10.9 Merck and Co. Inc.
o Exhibit 119: Merck and Co. Inc. - Overview
o Exhibit 120: Merck and Co. Inc. - Business segments
o Exhibit 121: Merck and Co. Inc. - Key news
o Exhibit 122: Merck and Co. Inc. - Key offerings
o Exhibit 123: Merck and Co. Inc. - Segment focus
o 10.10 Novo Nordisk AS
o Exhibit 124: Novo Nordisk AS - Overview
o Exhibit 125: Novo Nordisk AS - Business segments
o Exhibit 126: Novo Nordisk AS - Key offerings
o Exhibit 127: Novo Nordisk AS - Segment focus
o 10.11 Pfizer Inc.
o Exhibit 128: Pfizer Inc. - Overview
o Exhibit 129: Pfizer Inc. - Product / Service
o Exhibit 130: Pfizer Inc. - Key news
o Exhibit 131: Pfizer Inc. - Key offerings
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 132: Inclusions checklist
o Exhibit 133: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 134: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 135: Research methodology
o Exhibit 136: Validation techniques employed for market sizing
o Exhibit 137: Information sources
o 11.5 List of abbreviations
o Exhibit 138: List of abbreviations

Exhibits
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Application
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Application - Market share 2021-2026 (%)
Exhibits25: Data Table on Application - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Application
Exhibits27: Data Table on Comparison by Application
Exhibits28: Chart on Growth hormone deficiency - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Growth hormone deficiency - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Growth hormone deficiency - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Growth hormone deficiency - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on ISS - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on ISS - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on ISS - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on ISS - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Turner syndrome - Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Turner syndrome - Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Turner syndrome - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Turner syndrome - Year-over-year growth 2021-2026 (%)
Exhibits40: Chart on PWS - Market size and forecast 2021-2026 ($ million)
Exhibits41: Data Table on PWS - Market size and forecast 2021-2026 ($ million)
Exhibits42: Chart on PWS - Year-over-year growth 2021-2026 (%)
Exhibits43: Data Table on PWS - Year-over-year growth 2021-2026 (%)
Exhibits44: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibits45: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibits46: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibits47: Data Table on Others - Year-over-year growth 2021-2026 (%)
Exhibits48: Market opportunity by Application ($ million)
Exhibits49: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits50: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits51: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits52: Chart on Geographic comparison
Exhibits53: Data Table on Geographic comparison
Exhibits54: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Denmark - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on Denmark - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on Denmark - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Denmark - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits82: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits83: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits84: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits85: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits86: Chart on India - Market size and forecast 2021-2026 ($ million)
Exhibits87: Data Table on India - Market size and forecast 2021-2026 ($ million)
Exhibits88: Chart on India - Year-over-year growth 2021-2026 (%)
Exhibits89: Data Table on India - Year-over-year growth 2021-2026 (%)
Exhibits90: Market opportunity By Geographical Landscape ($ million)
Exhibits91: Impact of drivers and challenges in 2021 and 2026
Exhibits92: Overview on Criticality of inputs and Factors of differentiation
Exhibits93: Overview on factors of disruption
Exhibits94: Impact of key risks on business
Exhibits95: Vendors covered
Exhibits96: Matrix on vendor position and classification
Exhibits97: Abbott Laboratories - Overview
Exhibits98: Abbott Laboratories - Business segments
Exhibits99: Abbott Laboratories - Key offerings
Exhibits100: Abbott Laboratories - Segment focus
Exhibits101: Anhui Anke Biotechnology Group Co. Ltd. - Overview
Exhibits102: Anhui Anke Biotechnology Group Co. Ltd. - Product / Service
Exhibits103: Anhui Anke Biotechnology Group Co. Ltd. - Key offerings
Exhibits104: Ascendis Pharma AS - Overview
Exhibits105: Ascendis Pharma AS - Product / Service
Exhibits106: Ascendis Pharma AS - Key offerings
Exhibits107: F. Hoffmann La Roche Ltd. - Overview
Exhibits108: F. Hoffmann La Roche Ltd. - Business segments
Exhibits109: F. Hoffmann La Roche Ltd. - Key news
Exhibits110: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits111: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits112: Ferring B.V. - Overview
Exhibits113: Ferring B.V. - Product / Service
Exhibits114: Ferring B.V. - Key offerings
Exhibits115: Ipsen Pharma - Overview
Exhibits116: Ipsen Pharma - Business segments
Exhibits117: Ipsen Pharma - Key offerings
Exhibits118: Ipsen Pharma - Segment focus
Exhibits119: Merck and Co. Inc. - Overview
Exhibits120: Merck and Co. Inc. - Business segments
Exhibits121: Merck and Co. Inc. - Key news
Exhibits122: Merck and Co. Inc. - Key offerings
Exhibits123: Merck and Co. Inc. - Segment focus
Exhibits124: Novo Nordisk AS - Overview
Exhibits125: Novo Nordisk AS - Business segments
Exhibits126: Novo Nordisk AS - Key offerings
Exhibits127: Novo Nordisk AS - Segment focus
Exhibits128: Pfizer Inc. - Overview
Exhibits129: Pfizer Inc. - Product / Service
Exhibits130: Pfizer Inc. - Key news
Exhibits131: Pfizer Inc. - Key offerings
Exhibits132: Inclusions checklist
Exhibits133: Exclusions checklist
Exhibits134: Currency conversion rates for US$
Exhibits135: Research methodology
Exhibits136: Validation techniques employed for market sizing
Exhibits137: Information sources
Exhibits138: List of abbreviations